Cleveland BioLabs
CBLI
#9792
Rank
A$74.18 M
Marketcap
A$4.79
Share price
-7.31%
Change (1 day)
N/A
Change (1 year)

Earnings for Cleveland BioLabs (CBLI)

Earnings in 2021 (TTM): -A$3.69 Million

According to Cleveland BioLabs 's latest financial reports the company's current earnings are A$0.63 Million. In 2020 the company made an earning of -A$3.89 Million a decrease over its 2019 earnings that were of -A$3.57 Million.

Earnings history for Cleveland BioLabs from 2004 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-A$3.69 Million-5.17%
2020-A$3.89 Million8.8%
2019-A$3.57 Million-50.81%
2018-A$7.26 Million-14.3%
2017-A$8.47 Million-11.88%
2016-A$9.61 Million-50.9%
2015-A$19.58 Million-10.24%
2014-A$21.81 Million-37.5%
2013-A$34.89 Million-23.2%
2012-A$45.43 Million19.68%
2011-A$37.96 Million133.81%
2010-A$16.24 Million68.22%
2009-A$9.66 Million-55.51%
2008-A$21.69 Million-45.62%
2007-A$39.89 Million255.63%
2006-A$11.22 Million198.18%
2005-A$3.77 Million-1.25%
2004-A$3.81 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Onconova Therapeutics
ONTX
-A$27.46 Million 559.60%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-A$0.25 Billion 5,693.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.46 B-299,603.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$24.82 B-596,599.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Bristol-Myers Squibb
BMY
A$12.14 B-291,937.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$13.75 B-330,710.78%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
A$14.09 B-338,799.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-A$18.71 Million 349.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$34.02 B-817,651.66%๐Ÿ‡บ๐Ÿ‡ธ USA